Abstract:Background: China's National Essential Medicines Policy (NEMP) has been implemented for over 15 years; yet empirical evidence on its long-term impacts is lacking, particularly in remote and rural regions. This study aims to assess the short-and long-term effects of NEMP on the drug availability, price, and usage in a deprived rural county in southwestern China. Methods: A quasi-experimental design was employed, featuring a single-group pre-and-post comparison. We gathered 74,436 procurement records spanning from 2009 to 2016 from the drug warehouses of local medical institutions. Pharmaceutical data were analyzed quarterly, considering various policy and therapeutic attributes. Fisher's Drug Price Index (DPI-F) was calibrated for the retail and wholesale prices of a consistent collection of 405 medications. We conducted interrupted time-series analysis to examine the immediate and enduring impacts of NEMP's initial (commencing in January 2011) and second (starting from December 2015) stages. Results: After initiation of NEMP, the number of available essential medicines surged by 115 but subsequently faced a steady quarterly decline (-9.1) in township healthcare centers (THCs, primary care). Conversely, county hospitals (secondary care) initially saw a reduction of 40 in drug availability but later exhibited a steady increase (+4.2 per quarter) up to the second-stage NEMP. Regarding price, THCs encountered abrupt (-26.1%/-15.9% in retail/wholesale price) and sustained (-0.2%/-0.3% per quarter) price drops after NEMP. The immediate price change after NEMP in county hospitals were milder but significant in non-essential medicines, and long-term declines were also observed in all drugs. As for total sales, a significant long-term disparity emerged between THCs (+0.9% per quarter) and county hospitals (+3.3% per quarter). Following the second-stage NEMP, retail prices in county hospitals further decreased, although wholesale prices did not; however, following price upward trends were observed in both THCs and county hospitals. Lastly, the influences of NEMP varied across different therapeutical categories of medicines. Conclusion: NEMP has successfully regulated drug prices in primary and secondary healthcare facilities in remote and rural areas, both short-term and long-term. However, a remarkable disparity in medicine availability and utilization was observed between different levels of facilities over time. Continuous monitoring is essential, with increased attention needed on the uneven impacts of the policy on diverse drugs, facilities, regions, and demographics.

Effects of the Implementation of National Essential Drug System on Primary Sales Terminal Market Concentration Ratio of Pharmaceutical Commercial Enterprises in Shanghai

Effects of National Essential Drug System on Primary Terminal Market of Pharmaceutical Industrial Enterprises in Shanghai

Effect of National Essential Drug System on Financial Compensation of Community Health Centers in Shanghai

Supply of Essential Drugs in Community Health Centers in Shanghai Before and after the Implementation of National Essential Drug System

Effects of the Implementation of National Essential Drug System on Rational Use of Drugs in Community Health Service Center from Shanghai City

Changes of Drug Economic Burden of Patients in Shanghai after Implementation of National Essential Drug System

The impact of Chinese volume-based procurement on pharmaceutical market concentration

The Impact of the National Essential Medicines Policy on Rational Drug Use in Primary Care Institutions in Jiangsu Province of China.

Analyses on the effects of prescription review of key monitored drugs in one district of Shanghai

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China

The impact of National Centralised Drug Procurement policy on the use of policy-related original and generic drugs in China

The Impact of China's National Essential Medicine System on Improving Rational Drug Use in Primary Health Care Facilities: an Empirical Study in Four Provinces.

Contrastive analysis of some influencing factors of basic drug policy between Shanghai and Yunnan provinces

Implementation and Impact of National Centralized Drug Procurement Policy in China: Evidence from the National Drug Procurement Database

Short- and long-term impacts of the National Essential Medicines Policy on drug availability, price, and usage in a deprived rural county in southwestern China: an interrupted time series analysis across 8 years

Demand analysis of drugs outside the list of national essential medicines and Shanghai supplementary drugs in the community health centers of Shanghai

The Impact of the National Volume-Based Procurement Policy on the Use of Policy-Related Drugs in Nanjing: an Interrupted Time-Series Analysis

The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis

Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China

Preliminary analysis of pharmaceuticals zero mark-up policy in Shanghai

Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis